IL17A and juvenile idiopathic arthritis: Based on the studies that showed the role of IL-17 in the pathogenesis of JIA and, in particular, the role of the “IL-23–IL-17” axis, clinical studies were initially conducted to evaluate the effect of anti-IL23 biologics in the treatment of this disease.